CCNB1 and cancer: As displayed in Figures 3A,B, silencing CDK1/CCNB1 can promote the protein expressions of p53 and p21 in cancer cells (P < 0.05), while the result was reverse with the addition of PFT β, a p53 pathway inhibitor.